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Research
Despite successful efforts to reduce sources of 
lead exposure over the past several decades, 
lead remains ubiquitous in the environment, 
providing a source of exposure to humans. 
In addition, lead bioaccumulates in bone, 
where it has a half-life of approximately 
12–27 years, providing another source of 
exposure when it is mobilized (Bergdahl et al. 
1998; Gerhardsson et al. 1993). Previous 
research has shown that blood lead levels 
(BLLs) increase during periods of high bone 
turnover such as pregnancy (Gulson et al. 
1998, 1999; Hertz-Picciotto et al. 2000; 
Manton et al. 2003; Rothenberg et al. 1994), 
lactation (Gulson et al. 1998, 1999; Manton 
et al. 2003; Téllez-Rojo et al. 2002), meno-
pause (Garrido-Latorre et al. 2003; Gulson 
et al. 2002; Korrick et al. 2002; Silbergeld 
et al. 1988; Symanski and Hertz-Picciotto 
1995), and severe weight loss (Riedt et al. 
2009), with levels modified by calcium 
intake (Ettinger et al. 2009; Hernandez-
Avila et al. 2003; Hertz-Picciotto et al. 2000; 
Janakiraman et al. 2003). This increase in 
BLLs may put an individual at an increased 
risk for a variety of adverse health outcomes, 
because there is currently no known safe level 
of lead in blood.
To date, few studies have examined 
the association between markers of bone 
resorption and formation, and BLLs. Among 
pregnant women (n = 193) with high bone 
lead levels, Téllez-Rojo et al. (2004) found 
that plasma and whole BLLs increased sig-
nificantly with increased bone resorption 
as measured by cross-linked N-telopeptides 
(NTx). Within a population of Japanese 
women (n = 1,225), investigators observed 
significantly higher BLLs in relation to bone 
formation levels above the median among 
perimenopausal women regardless of bone 
resorption levels, but not among pre- or post-
menopausal women (Machida et al. 2009).
Because bone is continuously being 
remodeled, resulting in a constant, low-level 
exchange of lead between the blood and bone 
compartments (Rabinowitz et al. 1976), peri-
ods of low to moderate bone turnover may 
also be of importance among women with 
high bone lead levels (Silbergeld et al. 1993); 
however, little research has been done in 
this area. For this reason, as well as ongoing 
concerns associated with the adverse health 
effects of increased BLLs among adults (Berg 
2009), we examined associations among bone 
formation and resorption, micronutrient 
intake, and BLLs in women 20–85 years of 
age participating in the National Health and 
Nutrition Examination Survey (NHANES) 
1999–2002.
Materials and Methods
Data source. NHANES is a cross-sectional, 
national survey that assesses the health and 
nutrition of children and adults in the United 
States. In 1999, the survey became a continu-
ous, annual survey, with approximately 5,000 
individuals interviewed per year. The study 
population is a stratified, multistage probabil-
ity sample of the civilian, noninstitutionalized 
U.S. population. From 1999 to 2002, the 
study was oversampled for low-income per-
sons, adolescents, persons > 60 years of age, 
African Americans, and Mexican Americans. 
NHANES includes both a household inter-
view and mobile examination component. 
Detailed information regarding the NHANES 
survey can be found from the study Web site 
[Centers for Disease Control and Prevention 
(CDC) 2010]. This secondary data analysis 
was approved by the University Hospitals 
Case Medical Center Institutional Review 
Board under the exempt research category.
Study population. Women 20–85 years 
of age who participated in the mobile exami-
nation component and who completed the 
reproductive health questionnaire were eligible 
for analyses (n = 4,582). The study population 
was further limited to women with complete 
data on BLLs and markers of bone turnover 
(n = 4,255). Women were excluded if they fell 
into one or more of the following categories: 
menopausal status could not be determined 
(n = 80); pregnant (n = 470); lactating (n = 91); 
reported current thyroid disease (n = 140) or 
ever being diagnosed with diabetes (n = 371), 
kidney disease (n = 102), liver disease (n = 50), 
or cancer other than nonmelanoma skin cancer 
(n = 293); or had data missing on important 
confounders (n = 343). The final study popula-
tion included 2,671 women.
Menopausal status was determined 
by responses on the reproductive health 
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as the percent difference in geometric mean BLLs. 
re s u l t s: In adjusted analyses, mean BLLs among postmenopausal women in the upper tertiles 
of NTx and BAP were 34% [95% confidence interval (CI), 23%–45%] and 30% (95% CI, 
17%–43%) higher than BLLs among women in the lowest tertiles of NTx and BAP, respectively. 
These associations were weaker, but remained statistically significant, among premenopausal women 
(NTx: 10%; 95% CI, 0.60%–19%; BAP: 14%; 95% CI, 6%–22%). Within tertiles of NTx and 
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associated with lower mean BLLs among postmenopausal women but not premenopausal women, 
although most of the associations were not statistically significant. We observed similar associations 
for vitamin D supplement use. 
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questionnaire. Women reporting regular cycles 
and/or their last menstrual period within the 
preceding 60 days were considered premeno-
pausal. Women reporting their last menstrual 
period in the preceding 3–11 months were 
considered late perimenopausal unless they 
indicated “medical conditions/treatments” as 
a reason for their irregular menstrual cycles. 
Women who reported not having a menstrual 
period in the preceding 12 months unless 
due to “medical conditions/treatments” or 
who reported having a hysterectomy and/
or bilateral oophorectomy were considered 
postmenopausal. If women reported irregular 
cycles due to “medical conditions/  treatments” 
and did not have a menstrual period in the 
preceding 60 days, they were classified as 
“unable to determine.” Follicle-stimulating 
hormone levels were used to help classify 
menopausal status for approximately 10% of 
women 35–60 years of age whose menstrual 
cycle data were missing or inconsistent.
Measurement of bone turnover, lead, 
and micronutrients. NHANES measured 
bone-specific alkaline phosphatase (BAP), 
a marker of bone formation, in serum by 
either the Hybritech Tandem-MP Ostase 
ImmunoEnzyme assay (NHANES 1999–2001) 
or Beckman Access Ostase assay (NHANES 
2002). NTx, a marker of bone resorption, was 
measured in urine by   competitive-inhibition 
enzyme-linked solid-phase immunosorbent 
assay (Osteomark; NHANES 1999–2001) or 
Vitros Eci competitive assay (NHANES 2002). 
All NTx values were creatinine adjusted. 
Given the change in laboratory methods for 
both BAP and NTx during the 2001–2002 
study period, NHANES adjusted the meas-
ured values to account for the observed vari-
ability across methods (CDC 2008). An 
additional adjustment was made to BAP levels 
to trend the data over the full survey period, 
1999–2002, using regression methods recom-
mended by NHANES (CDC 2008). For the 
measurement of lead, blood was collected in 
EDTA-anticoagulant Vacutainers that were 
prescreened for background metal contamina-
tion. Lead was quantified in whole blood with 
a SIMAA 6000 simultaneous multielement 
atomic absorption spectrometer (Perkin-Elmer, 
Waltham, MA) with Zeeman background cor-
rection, with a minimum detection level of 
0.6 μg/dL and coefficients of variation ranging 
from 3.1% to 7.0%.
Data on use of calcium, iron, and vita-
min D supplements were based on self-re-
ported use in the past month. Each supplement 
reported by the participant was recorded, as 
well as the frequency of use and quantity taken. 
Detailed data on supplement ingredients were 
abstracted by NHANES staff, allowing for 
quantification of micronutrient supplement 
intake. Dietary nutrient intake of calcium and 
iron was quantified using a 24-hr dietary recall. 
Supplement and dietary intake were summed 
to estimate the total milligrams of calcium 
and iron intake per day, and dichotomized as 
less than or greater than/equal to the Dietary 
Reference Intake (DRI) for calcium (women 
19–50 years of age, 1,000 mg/day; > 50 years 
of age, 1,200 mg/day) and iron (women 
19–50 years of age, 18 mg/day; > 50 years 
of age, 8 mg/day) (Standing Committee on 
the Scientific Evaluation of Dietary Reference 
Intakes 1997, 2000). Because dietary data 
were not available for vitamin D and very 
few women had intakes above the DRI based 
on supplement use, vitamin D was analyzed 
as vitamin D supplement use in the past 
month (yes/no).
Measurement of confounders. Information 
on menarche, parity, sex hormone use, years 
since menopause (age at interview minus age 
at last menstrual period), and surgical meno-
pause was obtained from the reproductive 
health questionnaire. Surgical menopause 
was categorized as no history of hysterectomy 
or bilateral oophorectomy, history of hys-
terectomy without bilateral oophorectomy, 
or history of bilateral oophorectomy with or 
with  out hysterectomy. Women who reported 
currently using hormonal contraception or 
hormone replacement therapy were catego-
rized as currently using sex hormones.
A single variable indicating level of physi-
cal exercise was created based on self-reported 
moderate and vigorous activity over the pre-
ceding 30 days (no activity, moderate, and 
vigorous). A woman was considered to have 
participated in muscle-strengthening activities 
in the preceding 30 days if she reported doing 
any “physical activities specifically designed 
to strengthen your muscles such as lifting 
weights, push-ups, or sit-ups” during that 
time period. Osteoporosis and family history 
of osteoporosis were based on self-report by 
the woman of herself or her biological rela-
tives (living and deceased), respectively, ever 
being told by a health professional that they 
had osteoporosis or brittle bones. 
Data on other factors of interest such as 
demographics, body mass index (BMI), alco-
hol and cigarette use, and housing charac-
teristics were obtained from their respective 
questionnaires. Poverty income ratio, as cal-
culated by NHANES, was used as a measure 
of socioeconomic status and is the ratio of 
income to the family’s appropriate poverty 
threshold as determined by family size and 
composition. Values < 1.00 represent a fam-
ily living below the official poverty thresh-
old, whereas values ≥ 1.00 indicate income 
at or above the poverty level. Poverty income 
ratio was dichotomized for analyses (< 2.0 and 
≥ 2.00). BMI was categorized according to 
World Health Organization criteria (< 25.0, 
25.0–29.9, and ≥ 30 kg/m2) (World Health 
Organization 1995).
Statistical analysis. Geometric mean 
BLLs were compared across categories of 
demographic, lifestyle, and reproductive 
health factors using the Kruskal–Wallis test, 
because BLLs were not normally distributed. 
The associations between tertiles of NTx and 
BAP, and BLLs were examined using lin-
ear regression with natural log-transformed 
BLLs as the dependent variable. Results were 
back-  transformed and interpreted as the 
percent difference in geometric mean BLLs 
compared with levels in the lowest tertile of 
exposure. BAP and NTx were modeled sepa-
rately because they were highly correlated 
(r = 0.37; p < 0.001). Factors shown in the 
literature to be associated with BLLs, NTx, or 
BAP or that changed the association between 
markers of bone turnover and BLLs by > 10% 
were examined as potential confounders; all 
variables were entered as categorized in Table 1 
except age, which was entered as a continuous 
variable. Only those variables that confounded 
the association between exposure and outcome 
were retained in the final models. Further anal-
yses were stratified by menopausal status; late 
perimenopausal women were not examined 
separately given the small number of women. 
In subanalyses, we examined the association 
between NTx and BLLs within tertiles of BAP.
To examine associations between supple-
ment use or micronutrient intake and percent 
difference in mean BLLs, any supplement use 
in the past month (yes/no), total daily cal-
cium and iron intake (dichotomized at DRI), 
and vitamin D supplement use in the past 
month (yes/no) were modeled independently 
and in a single model with adjustment for 
potential confounders, including NTx and 
BAP. We further examined potential inter-
actions between each micronutrient, and BAP 
and NTx in adjusted analyses.
The 4-year mobile-examination-  component 
sample weights were used for regression analy-
ses taking into account the complex sam-
pling design of NHANES and nonresponse 
of eligible participants. Sampling errors were 
estimated using the Taylor series linearized 
method. Study results were considered statisti-
cally significant if the p-value was < 0.05; how-
ever, some results may be significant by chance. 
All analyses were completed in STATA 9.0 
(StataCorp LP, College Station, TX).
Results
Among eligible women, 1,359 were pre-
menopausal, 58 late perimenopausal, and 
1,254 postmenopausal (median age since last 
menstrual period = 17 years; interquartile range 
= 8–27 years). The geometric mean BLL for 
the overall population was 1.44 μg/dL [95% 
confidence interval (CI), 1.41–1.48 μg/dL], 
with peri- and postmenopausal women hav-
ing higher BLLs compared with premeno-
pausal women (Table 1). White non-Hispanic Jackson et al.
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women had lower mean BLLs than did black 
non-Hispanic women. Women who con-
sumed one or more drinks per week or were 
former or current smokers had higher BLLs 
than did women who consumed less than one 
drink per week or were never-smokers, respec-
tively. Exercise or muscle-strengthening activi-
ties in the preceding 30 days, current use of 
sex hormones, and calcium intake above the 
DRI were associated with lower BLLs, whereas 
iron intake above the DRI was associated with 
higher BLLs. Women who reported being 
diagnosed with osteoporosis had higher BLLs 
than did those who did not have osteoporosis, 
whereas those with a family history of osteo-
porosis had lower BLLs than did those without 
a family history. BLLs were higher among 
women living in homes built before 1960 (vs. 
1960 or later), having their NHANES exami-
nation between 1 May and 31 October (vs. 
between 1 November and 30 April), and not 
using a water treatment device in their home 
(vs. using a device; data not shown).
Geometric mean BLLs increased by ter-
tiles of both BAP and NTx (p-value for trend 
< 0.001) in the overall study population 
(Table 1). Women in the second and third 
tertiles of NTx and BAP had higher mean 
BLLs than did women in the lowest tertile of 
each exposure (Table 2). After adjusting for 
age, menopausal status, race/ethnicity, current 
hormone use, surgical menopause, smoking 
status, and BMI, mean BLLs were significantly 
higher among women in the second and third 
tertiles of NTx relative to the lowest tertile 
(5% higher; 95% CI, 0.13–11.06%; 18% 
higher; 95% CI, 11.63–24.78%, respectively). 
Adjusted mean BLLs were also significantly 
higher among women in the second (7%; 
95% CI, 1.09–14.28%) and third (20%; 95% 
CI, 13.68–27.44%) tertiles of BAP compared 
with the first, respectively. These results did 
not change in sensitivity analyses in which 
a) we included in analyses women originally 
excluded for exclusionary diagnoses, and b) we 
excluded from analyses women with osteo-
porosis or family history of osteoporosis. 
NTx and BAP were also associated with 
higher mean BLLs when we examined pre-
menopausal and postmenopausal women 
separately (Table 3). Among premenopausal 
women, adjusted mean BLLs were 10% (95% 
CI, 0.60–19.21%) and 14% (95% CI, 6.49–
22.08%) higher for women in the highest ver-
sus lowest tertile of NTx and BAP, respectively. 
Among postmenopausal women, adjusted 
mean BLLs were 15% (95% CI, 5.18–26.75%) 
and 34% (95% CI, 23.31–45.39%) higher for 
women in the second and third tertiles of NTx, 
and 13% (95% CI, 1.12–25.99%) and 30% 
(95% CI, 17.93–43.36%) higher for women 
in the second and third tertiles of BAP, rela-
tive to women in the first tertile of each expo-
sure. These associations did not change after 
adjusting for years since menopause, although 
BLLs decreased by approximately 0.8% for 
each additional year since menopause (NTx: 
–0.73%; 95% CI, –1.29% to –0.17%; BAP: 
–0.80; 95% CI, –1.36% to –0.24%).
We explored the association between NTx 
and BLLs within tertiles of BAP for both pre- 
and postmenopausal women. Within each ter-
tile of BAP, premenopausal women with higher 
NTx levels had higher mean BLLs than did 
women with lower NTx levels. The adjusted 
mean BLL in postmenopausal women in the 
highest tertiles of both NTx and BAP was 
51% higher (95% CI, 31.45–72.81%) than 
women in the lowest tertiles of both exposures 
(Figure 1). We observed similar patterns for 
Variable n
Geometric 
mean (μg/dL) 95% CIa
NTx (nM bone collagen equivalent/mM creatinine)
0–27.39 891 1.29 1.25–1.34
27.40–40.76 890 1.36 1.31–1.42
40.77–934.58 890 1.71 1.63–1.78
BAP (μg/L)
0–10.30 901 1.23 1.19–1.28
10.31–14.40 886 1.39 1.34–1.45
14.41–153.00 884 1.76 1.68–1.83
Age (years)
20–34 678 1.00 0.96–1.05
35–59 1,190 1.45 1.40–1.50
≥ 60 803 1.95 1.88–2.03
Menopausal status
Premenopausal 1,359 1.14 1.10–1.18
Late perimenopausal 58 1.69 1.45–1.98
Postmenopausal 1,254 1.85 1.79–1.91
Race/ethnicity
Non-Hispanic white 1,300 1.39 1.34–1.43
Non-Hispanic black 512 1.56 1.47–1.65
Other 859 1.47 1.40–1.53
Poverty income ratio
< 2.00 1,010 1.54 1.47–1.60
≥ 2.00 1,400 1.33 1.29–1.37
Missing 261 1.77 1.64–1.90
BMI (kg/m2)
< 25.0 941 1.44 1.38–1.50
25.0–29.9 817 1.53 1.46–1.59
≥ 30.0 913 1.38 1.32–1.44
Osteoporosis
No 2,495 1.43 1.39–1.46
Yes 176 1.67 1.54–1.82
Family history of osteoporosis
No 2,215 1.46 1.43–1.50
Yes 456 1.34 1.27–1.43
Current smoking status
Never 1,650 1.32 1.28–1.36
Former 505 1.58 1.50–1.66
Current 516 1.77 1.68–1.87
Variable n
Geometric 
mean (μg/dL) 95% CIa
Alcohol consumption in preceding 12 months
< 1 drink/week 1,981 1.41 1.37–1.45
≥ 1 drinks/week 690 1.54 1.47–1.62
Any supplement use in past month
No 1,248 1.47 1.41–1.52
Yes 1,423 1.42 1.38–1.47
Calcium intakeb
< DRI 2,041 1.49 1.45–1.53
≥ DRI 564 1.28 1.22–1.34
Iron intakeb
< DRI 1,416 1.35 1.30–1.39
≥ DRI 1,141 1.58 1.53–1.64
Vitamin D supplement use in preceding month
No 2,335 1.44 1.41–1.48
Yes 336 1.43 1.35–1.52
Exercise in preceding 30 days
No exercise 1,197 1.65 1.59–1.71
Moderate 723 1.38 1.32–1.44
Vigorous 751 1.22 1.17–1.28
Muscle-strengthening activities in preceding 30 days
No 2,093 1.51 1.46–1.55
Yes 578 1.24 1.18–1.30
Current hormone use
No 2,058 1.52 1.47–1.56
Yes 613 1.22 1.17–1.28
Parity (live births)
None 488 1.15 1.09–1.22
1 370 1.44 1.35–1.54
2 645 1.39 1.33–1.46
≥ 3 1,168 1.62 1.56–1.68
Surgical menopause
No surgery 2,084 1.39 1.35–1.42
Hysterectomy, 
no bilateral 
oophorectomy
318 1.63 1.53–1.74
Oophorectomy 269 1.71 1.58–1.84
Table 1. Geometric mean BLLs (unweighted) by population characteristics of women 20–85 years of age 
participating in NHANES 1999–2002 (n = 2,671).
aBlood levels differed significantly (p < 0.01) across variable categories except for any supplement use (p = 0.50) and 
vitamin D supplement use (p = 0.92), Kruskal–Wallis test. bThe following variables had missing observations: calcium 
intake (n = 66) and iron intake (n = 114).
Table 2. Unadjusted and adjusted linear regression models for the association between tertiles of bone 
formation (serum BAP) and resorption (creatinine-adjusted urinary NTx) and percent difference in 
  geometric mean BLLs, NHANES 1999–2002 (n = 2,671).
Unadjusted modela Final modela,b
Tertile n Percent difference 95% CI Percent difference 95% CI
NTx (nM bone collagen equivalent/mM creatinine)
0–27.3 891 Reference Reference
27.40–40.76 890 4.96 –0.39 to 10.59 5.45 0.13 to 11.06
40.77–934.58 890 25.34 17.42 to 33.79 18.03 11.63 to 24.78
BAP (μg/L)
0–10.30 901 Reference Reference
10.31–14.40 886 11.55 2.91 to 20.91 7.48 1.09 to 14.28
14.41–153.00 884 38.91 29.80 to 48.65 20.37 13.68 to 27.44
aNTx and BAP were modeled independently. bModel adjusted for age, menopausal group, race/ethnicity, current hor-
mone use, surgical menopause, smoking status, and BMI.Bone turnover, micronutrient intake, and blood lead levels
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premenopausal women: Mean adjusted BLL 
in women in the highest tertiles of both NTx 
and BAP was 19% (95% CI, 5.66–34.78%) 
higher than in women in the lowest tertiles of 
both BAP and NTx [Supplemental Material, 
Figure 1 (doi:10.1289/ehp.1002158)]. 
Despite these findings, we found no statisti-
cally significant multiplicative interaction 
between BAP and NTx for either pre- or 
postmenopausal women.
Micronutrient intake. In postmenopausal 
women, use of any supplements and use of 
vitamin D supplements in the past month 
were both associated with significantly lower 
adjusted mean BLLs, whereas we found a 
nonsignificant difference with calcium intake 
above and below the DRI (Table 4). These 
associations did not change substantially 
after adjusting for iron and for calcium or 
vitamin D intake. Iron intake was associated 
with slightly lower mean BLLs among post-
menopausal women (Table 4); however, this 
association weakened after adding calcium and 
vitamin D to the models. Any supplement use 
was associated with lower mean BLLs among 
premenopausal women (NTx: –9.54% ; 95% 
CI, –16.68% to –1.79%; BAP: –9.15%; 95% 
CI, –16.50% to –1.16%); however, we found 
no association between specific micronutrients 
and BLLs in this group (data not shown).
Neither micronutrient intake nor supple-
ment use appeared to modify associations 
between BAP or NTx and BLLs. Among 
postmenopausal women, any supplement use 
(vs. no use) [Supplemental Material, Figure 2 
(doi:10.1289/ehp.1002158)], calcium use at 
or above the DRI (vs. < DRI) (Figure 2A), 
and vitamin D supplement use (vs. no use) 
(Figure 2B) were associated with lower mean 
BLLs within tertiles of BAP and NTx. Within 
the lowest tertile of BAP and NTx, respectively, 
postmenopausal women with calcium intake 
above the DRI had 12% (95% CI, –21.67% 
to –0.97%) and 18% (95% CI, –29.63% to 
–4.04%) lower mean BLLs compared with 
those with intake below the DRI after adjust-
ing for potential confounders (Figure 2A). 
Vitamin D supplement use did not significantly 
alter mean BLLs; however, we found some evi-
dence that it was associated with lower mean 
BLLs, as observed for calcium (Figure 2B). 
Iron intake among postmenopausal women did 
not greatly alter BLLs [Supplemental Material, 
Figure 3 (doi:10.1289/ehp.1002158)]. Among 
premenopausal women, any supplement use in 
the past month was associated with lower mean 
BLLs across most tertiles of NTx and BAP 
[Supplemental Material, Figure 4 (doi:10.1289/
ehp.1002158)]; however, we found no clear 
association for specific   micronutrients.
Discussion
In this representative sample of the U.S. non-
institutionalized female population, we found 
that both bone formation (serum BAP) and 
bone resorption (creatinine-adjusted urinary 
NTx) were significantly associated with higher 
mean BLLs among pre- and postmenopausal 
women. Furthermore, calcium intake and 
vitamin D supplement use among postmeno-
pausal women were associated with lower 
mean BLLs across most tertiles of NTx and 
Figure 1. Percent difference (95% CI) in geometric mean BLLs by tertiles of bone formation (serum BAP) 
and resorption (creatinine-adjusted urinary NTx), relative to the lowest tertiles of BAP and NTx and 
adjusted for age, race/ethnicity, current hormone use, smoking status, BMI, surgical menopause, supple-
ment use, and alcohol consumption: postmenopausal women, NHANES 1999–2002 (n = 1,254). 
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Table 3. Adjusted linear regression models for the association between tertiles of bone formation (serum 
BAP) and resorption (creatinine-adjusted urinary NTx) and percent difference in geometric mean BLLs 
stratified by menopausal status, NHANES 1999–2002.
Premenopausala (n = 1,359) Postmenopausalb (n = 1,254)
Tertile n Percent difference 95% CI n Percent difference 95% CI
NTx (nM bone collagen equivalent/mM creatinine)
0–27.39 507 Reference 369 Reference
27.40–40.76 480 0.64 –5.42 to 7.08 387 15.46 5.18 to 26.75
40.77–934.58 372 9.51 0.60 to 19.21 498 33.90 23.31 to 45.39
BAP (μg/L)
0–10.30 569 Reference 319 Reference
10.31–14.40 479 6.06 –1.52 to 14.22 384 12.87 1.12 to 25.99
14.41–153.00 311 14.02 6.49 to 22.08 551 30.03 17.93 to 43.36
aNTx and BAP modeled independently and adjusted for age, race/ethnicity, current hormone use, smoking status, and 
BMI. bNTx and BAP modeled independently and adjusted for age, race/ethnicity, current hormone use, smoking status, 
BMI, surgical menopause, supplement use, and alcohol consumption.
Table 4. Adjusted linear regression models for the association between micronutrient intake or supplement 
use and percent difference in geometric mean BLLs among postmenopausal women, NHANES 1999–2002.
Independent modelb Single modelc
Micronutrient/supplementa n
Percent 
difference 95% CI
Percent 
difference 95% CI
NTx model
Any supplement use 1,254 –11.81 –18.51 to –4.56 NA
Calcium intake 1,226 –9.50 –19.58 to 1.84 –8.39 –18.21 to 2.60
Iron intake 1,216 –5.07 –12.63 to 3.15 –2.20 –9.38 to 5.53
Vitamin D supplement use 1,254 –12.52 –17.60 to –7.13 –12.52 –16.88 to –6.68
BAP model
Any supplement use 1,254 –12.84 –19.75 to –5.33 NA
Calcium intake 1,226 –9.72 –19.64 to 1.43 –8.66 –18.28 to 2.11
Iron intake 1,216 –4.76 –11.85 to 2.90 –1.77 –8.46 to 5.40
Vitamin D supplement use 1,254 –12.77 –17.87 to –7.35 –12.15 –17.15 to –6.85
NA, not applicable.
aCalcium and iron intake were dichotomized at the age-specific DRI level (≥ DRI vs. < DRI). Any supplement use and vita-
min D supplement use were dichotomized (yes vs. no). bIndependent models for percent difference in geometric mean 
BLLs for each micronutrient/ supplement, adjusted for NTx (NTx models) or BAP (BAP models), age, race/ethnicity, cur-
rent hormone use, smoking status, BMI, surgical menopause, and alcohol consumption. cSingle models (n = 1,210) for 
percent difference in geometric mean BLLs for all micronutrients, including calcium, iron, and vitamin D, and adjusted 
for NTx (NTx model) or BAP (BAP model), age, race/ethnicity, current hormone use, smoking status, BMI, surgical 
menopause, and alcohol consumption.Jackson et al.
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BAP, although the effect estimates were 
imprecise.
Although many sources of lead exposure 
have been reduced or eliminated over the 
past three decades, lifetime exposure to these 
sources remains a threat to human health 
because of the bioaccumulation of lead in 
bone. Approximately 92% of lead that enters 
the body will be excreted through urine and 
feces (International Programme on Chemical 
Safety 1995); however, 90% of the remaining 
lead is taken up by the bones and teeth, where 
it has a half-life of 12–27 years (Bergdahl 
et al. 1998; Gerhardsson et al. 1993). Higher 
bone lead levels have been associated with 
increasing age, black race, increasing pack-
years of smoking, increasing alcohol intake, 
lower parity, never breast-feeding, use of lead-
glazed pottery, and occupational lead expo-
sure (Brown et al. 2000; Korrick et al. 2002; 
Lin et al. 2004; Popovic et al. 2005). Those 
with higher bone lead stores may be at an 
increased risk for higher BLLs when lead is 
mobilized from bone tissue during regular 
bone turnover and periods of high bone turn-
over, as observed in this study.
Bone is continuously being remodeled; 
however, periods of high turnover may be of 
particular concern (Roberts and Silbergeld 
1995). Within our analyses of post  menopausal 
women, those in the upper tertile of both 
BAP and NTx had an estimated mean BLL 
that was 51% higher than the mean BLL of 
women in the lowest tertiles of BAP and NTx. 
Furthermore, we observed significant positive 
associations with high (vs. low) BAP among 
women with low NTx, and with high (vs. low) 
NTx among women with low BAP (Figure 1), 
consistent with potential independent 
effects of bone formation and bone resorp-
tion on BLLs, respectively. The independent 
association of BAP with BLL was unexpected 
but may reflect the true physiology of bone 
turnover in which new bone formation closely 
follows bone resorption in any given segment 
of bone; however, it may be difficult to truly 
separate these effects statistically given their 
strong correlation. Among a population of 
perimenopausal women, Machida et al. (2009) 
observed a similar independent effect of bone 
formation (BAP) on BLLs, regardless of the 
level of bone resorption (NTx). Alternatively, 
the association we observed may be due to 
residual confounding related to the assay or the 
use of tertiles, or may be due to chance. Potula 
et al. (2005) observed a significant increase in 
BLLs related to menopausal stage, similar to 
our observations; however, in their adjusted 
analyses (n = 73) neither bone formation nor 
bone resorption was significantly associated 
with BLLs in pre- or postmenopausal women. 
Our results provide further support for 
studies that observed higher BLLs among peri- 
and postmenopausal women compared with 
premenopausal women but did not measure 
markers of bone turnover (Garrido-Latorre 
et al. 2003; Gulson et al. 2002; Korrick et al. 
2002; Silbergeld et al. 1988; Symanski and 
Hertz-Picciotto 1995). Several of these stud-
ies reported significant associations between 
bone lead levels and BLLs while adjusting for 
other factors (Berkowitz et al. 2004; Garrido-
Latorre et al. 2003; Korrick et al. 2002). 
As shown by Téllez-Rojo et al. (2004) in a 
cohort of pregnant women, both the bioavail-
ability of lead in bone and the level of bone 
resorption are important predictors of BLLs. 
Although we did not have bone lead mea-
surements, the stronger association observed 
among postmenopausal women compared 
with premenopausal women within the same 
tertiles of bone formation and resorption 
may be explained by potentially higher bone 
lead stores in postmenopausal women due to 
higher lifetime exposures and a longer dura-
tion of exposure, and therefore increased bio-
availability of lead in bone.
Lead exposure remains a concern given 
the growing number of adverse health effects 
observed in both children and adults at lev-
els well below the current levels of concern 
set by the CDC (1991; children and preg-
nant women, 10 μg/dL; adults, 25 μg/dL) 
and the Occupational Safety and Health 
Administration (1978; 40 μg/dL), with no 
known safe level of lead in blood currently 
identified. Higher BLLs in adults have been 
associated with adverse pregnancy and repro-
ductive outcomes (Bellinger 2005; Chang 
et al. 2006; Popovic et al. 2005; Tang and 
Zhu 2003), chronic kidney and cardiovascu-
lar disease (Navas-Acien et al. 2007, 2009), 
impaired cognitive function (Weuve et al. 
2009), osteoporosis (Campbell and Auinger 
2007), fractures (Khalil et al. 2008), meno-
pausal age (Popovic et al. 2005), and over-
all and cardiovascular mortality (Weisskopf 
et al. 2009); therefore, it is important to iden-
tify factors that may modify the association 
between bone formation and resorption and 
BLLs. To this end, we examined associations 
between calcium, iron, and vitamin D intake 
and BLLs, given their importance in lead 
absorption and/or bone turnover (Avendano-
Badillo et al. 2009; Ettinger et al. 2009; 
Hernandez-Avila et al. 2003; Hertz-Picciotto 
et al. 2000; Janakiraman et al. 2003). Calcium 
and vitamin D intake were associated with 
lower mean BLLs across most tertiles of NTx 
and BAP among postmenopausal women, but 
not among premenopausal women. A similar 
association between calcium and BLLs has 
been observed among pregnant and lactating 
Figure 2. Percent difference (95% CI) in geometric mean BLLs by type of micronutrient and tertiles of bone formation (serum BAP) and resorption (creatinine-
adjusted urinary NTx), relative to no intake or use in the lowest tertile of BAP or NTx and adjusted for age, race/ethnicity, current hormone use, smoking status, 
BMI, surgical menopause, supplement use, and alcohol consumption: postmenopausal women, NHANES 1999–2002. (A) Calcium intake below and above the DRI 
(n = 1,226). (B) Vitamin D supplement use in the past month (n = 1,254).
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women (Ettinger et al. 2009; Hernandez-
Avila et al. 2003; Hertz-Picciotto et al. 2000), 
consistent with the increased bone turnover 
experienced by these women. In contrast, 
Potula et al. (2005) observed a significant 
positive association between serum ionized 
calcium levels and BLLs among postmeno-
pausal women (n = 47), but a nonsignificant, 
inverse relationship among premenopausal 
women (n = 26) in adjusted analyses; they 
observed no association between serum vita-
min D levels and BLLs.
Given the cross-sectional nature of this 
analysis, it is not possible to determine 
whether bone formation and resorption are 
causally associated with increased BLLs. 
Furthermore, it is unclear where micronu-
trient intake may fall in the causal pathway 
because some women may increase their 
intake to prevent bone resorption or osteo-
porosis, whereas others may increase intake 
as treatment for these conditions. For this 
reason, we excluded women with medical 
conditions that may alter bone resorption or 
formation. In sensitivity analyses, the addition 
of these women to the analyses, as well as the 
exclusion of women with osteoporosis or fam-
ily history of osteoporosis from the analyses, 
did not change the associations between NTx 
and BAP, and BLLs.
Using data on both supplement use and 
dietary intake, we were able to estimate the 
daily intake of calcium and iron in relation to 
DRIs. We estimated vitamin D intake using 
self-reported vitamin D supplement use only, 
which may have resulted in measurement error 
for this variable because the primary sources of 
vitamin D are through diet and sunlight expo-
sure; therefore, these results should be inter-
preted cautiously. Given that micronutrient 
exposures do not occur singularly, but rather as 
mixtures, in our primary analyses we used “any 
supplement use in the past month,” which 
was a stronger predictor of BLLs than any one 
micronutrient alone. In secondary analyses, 
we also generated models including all three 
micronutrients and did not find major changes 
in the point estimates for BAP or NTx.
NTx levels in our study were similar to 
those observed in the Study of Women’s 
Health Across the Nation (Sowers et al. 2003) 
but lower than those observed by Machida 
et al. (2009), as were BAP levels. These dif-
ferences may be attributable to differences in 
study populations and eligibility criteria, tim-
ing of urine collection, or both. Machida et al. 
(2009) appropriately obtained samples from a 
second-morning urinary void, whereas collec-
tion of samples was untimed for NHANES. 
Despite the lower levels of NTx and BAP 
observed in our analyses compared with those 
of Machida et al. (2009), we still observed a 
significant association between these markers 
and BLLs.
Finally, based on the NHANES data, we 
could not delineate whether lead as measured 
in blood was primarily from bone stores or 
from new sources of environmental or occu-
pational lead exposure. We did examine age 
of homes as an indicator of lead paint in the 
home, season of examination as a marker of 
increased environmental exposure during the 
summer months, and use of water treatment 
devices as a means of removing lead from water 
in the home. Age of home was missing for a 
large proportion of individuals (21%), and 
although living in homes built before 1960 
was associated with significantly higher BLLs, 
it did not change the estimates for BAP or 
NTx in adjusted analyses. Season (1 May to 31 
October vs. 1 November to 30 April) was asso-
ciated with significantly higher BLLs, and use 
of water treatment devices with significantly 
lower BLLs, but neither confounded the asso-
ciations between NTx and BAP, and BLLs.
Conclusions
Within this study of “healthy” pre-, peri-, 
and postmenopausal women participating 
in NHANES 1999–2002, we observed sig-
nificantly higher mean BLLs with increasing 
levels of bone formation (serum BAP) and 
resorption (creatinine-adjusted urinary NTx). 
We observed 20% and 51% increases in BLLs 
among pre- and postmenopausal women, 
respectively, who were in the highest tertiles 
of bone formation and resorption compared 
with those in the lowest tertiles. This suggests 
that women with higher levels of bone forma-
tion and resorption may be at increased risk 
for lead-associated morbidity and mortality. 
Among postmenopausal women, but not pre-
menopausal women, calcium and vitamin D 
intake were associated with lower mean BLLs. 
Further elucidation of associations among 
bone lead levels, bone turnover, micronutri-
ent intake, and BLLs is needed in prospective 
studies. Health care providers should continue 
to emphasize the importance of adequate cal-
cium and vitamin D intake among women to 
prevent osteoporosis and other adverse health 
conditions, as well as to reduce the potential 
impact of bone turnover on BLLs.
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